Of note, secretory form STIP1 could stimulate HCC progression in an autocrine manner (21), which led us to raise the hypothesis that serum STIP1 might be a potential biomarker for predicting prognosis of HCC. Here, STIP1 is linked to hepatocellular carcinoma.